MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, AIDX made $353,375 in revenue. -$2,120,644 in net income. Net profit margin of -600.11%.

Income Overview

Revenue
$353,375
Net Income
-$2,120,644
Net Profit Margin
-600.11%
EPS
-$0.28
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
Revenues
353,375 511,283.25*
Cost of revenues
290,491 360,148*
Gross profit
62,884 151,135.25*
Sales, general and administrative
1,352,758 835,710.75*
Research and development
153,482 148,142.25*
Total operating expenses
1,506,240 983,853*
Operating loss
-1,443,356 -832,717.75*
Interest expense
267,008 39,051.75*
Interest income
6,653 5,349.75*
Loss on change in fair value of warrant liability
-148,766 1,934.25*
Loss on issuance of convertible note
-322,359 -70,191*
Other (expense) income, net
--28.75*
Total other (expense) income
-731,480 -101,987.5*
Net loss
-2,174,836 -934,705.25
Dividend on preferred stock
-54,192 -
Net loss attributable to common stockholders
-2,120,644 -
Basic EPS
-0.28 -0.19
Diluted EPS
-0.28 -0.19
Basic Average Shares
7,657,229 4,930,287
Diluted Average Shares
7,657,229 4,930,287
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$2,120,644 Dividend on preferredstock-$54,192 Net loss-$2,174,836 Revenues$353,375 Operating loss-$1,443,356 Total other (expense)income-$731,480 Gross profit$62,884 Interest income$6,653 Cost of revenues$290,491 Total operatingexpenses$1,506,240 Loss on issuance ofconvertible note-$322,359 Interest expense$267,008 Loss on change in fairvalue of warrant...-$148,766 Sales, general andadministrative$1,352,758 Research and development$153,482

20 20 Biolabs, Inc. (AIDX)

20 20 Biolabs, Inc. (AIDX)